Rhythm Pharmaceuticals gets EU approval for obesity drug IMCIVREE

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. MU
6. SPY
7. KBH
8. HON
9. HTZ
10. GOOGL

Go back to Rhythm Pharmaceuticals gets EU approval for obesity drug IMCIVREE
(NASDAQ: RYTM) Delayed: 107.55 +1.36 (1.28%)
Previous Close $106.19    52 Week High $ 
Open $107.56    52 Week Low $ 
Day High $111.13    P/E N/A 
Day Low $106.62    EPS $ 
Volume 1,263,045